Prognostic significance of vitamin d receptor polymorphisms in head and neck squamous cell carcinoma

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Hama, Takanori ^a   Norizoe, Chihiro ^a   Suga, Hiroaki ^a,b   Mimura, Takeshi ^a,b   Kato, Takakuni ^a   Moriyama, Hiroshi ^a   Urashima, Mitsuyoshi ^a,b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PROGNOSIS; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR GROWTH; ALLELE; DISEASE FREE SURVIVAL; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CALCITRIOL;

EID: 84855259665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029634     Document Type: Article

References (33)

1. Grant WB, Mohr SB, (2007) Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 19: 446-454.
2. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
3. Nonn L, Peng L, Feldman D, Peehl DM, (2006) Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res 66: 4516-4524.
4. Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, et al. (2006) Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 66: 4574-4583.
5. El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, et al. (2000) The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res 60: 4412-4418.
6. Chung I, Han G, Seshadri M, Gillard BM, Yu WD, et al. (2009) Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res 69: 967-975.
7. Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, et al. (2009) Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res 2: 213-223.
8. Garland CF, Gorham ED, Mohr SB, Garland FC, (2009) Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19: 468-483.
9. Giovannucci E, (2009) Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19: 84-88.
10. Raimondi S, Johansson H, Maisonneuve P, Gandini S, (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30: 1170-1180.
11. Gandini S, Raimondi S, Gnagnarella P, Dore JF, Maisonneuve P, et al. (2009) Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 45: 634-641.
12. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP, (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591.
13. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354: 684-696.
14. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, et al. (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100: 1581-1591.
15. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, et al. (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991.
16. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N, (2009) Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer. J Clin Oncol 23: 3757-3763.
17. Lundin AC, Söderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S, (1999) Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 59: 2332-2334.
18. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, et al. (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25: 479-485.
19. Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, et al. (2008) Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 26: 5596-5602.
20. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP, (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143-156.
21. Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, et al. (2009) Prognostic Significance of Epidermal Growth Factor Receptor Phosphorylation and Mutation in Head and Neck Squamous Cell Carcinoma. Oncologist 14: 900-908.
22. Haploview website. Available: http://www.broadinstitute.org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview. Accessed 2011 Dec 3.
23. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12: 915-921.
24. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhager JC, et al. (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol 52: 211-216.
25. Alimirah F, Peng X, Murillo G, Mehta RG, (2011) Functional Significance of Vitamin D Receptor FokI Polymorphism in Human Breast Cancer Cells. Plos One 24: e16024.
26. Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, et al. (2001) Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst 93: 745-775.
27. Satake K, Takagi E, Ishii A, Kato Y, Imagawa Y, et al. (2003) Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma. Auris Nasus Larynx 30: 403-412.
28. Lu L, Qiu J, Liu S, Luo W, (2008) Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57. Mol Cancer Ther 7: 1268-1274.
29. Hager G, Kornfehl J, Knerer B, Weigel G, Formanek M, (2004) Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs. Acta Otolaryngol 124: 90-96.
30. Meier JD, Enepekides DJ, Poirier B, Bradley CA, Albala JS, et al. (2007) Treatment with 1-alpha,25-dihydroxyvitamin D3 (vitamin D3) to inhibit carcinogenesis in the hamster buccal pouch model. Arch Otolaryngol Head Neck Surg 133: 1149-1152.
31. Kulbersh JS, Day TA, Gillespie MB, Young MR, (2009) 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg 140: 235-240.
32. Young MR, Wright MA, Lozano Y, Prechel M, Benefield J, et al. (1997) Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer 74: 69-74.
33. Liu Z, Calderon JI, Zhang Z, Sturgis EM, Spitz MR, et al. (2005) Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics 15: 159-165.